The Venture Codex Logo

The Venture Codex

Euclidean Capital

160 5th Ave, Fl 9, New York, NY, 10010, United States

Overview

Investment firm focused on individual and family services management.

Founded

2009

Deals ยท 12mo

6

Links

LinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

Business Development
Finance
Financial Services

Investment portfolio

54rounds
NAMEDATESIZE
Circle Pharma
Sep 2026Participated
$93 MSeries E
Savvy Wealth
Sep 2026Participated
$100 MSeries C
Leal Therapeutics
Aug 2026Participated
$30 MSeries A
InduPro
Aug 2026Participated
$77 MSeries B
Nura Bio
Jun 2026Participated
$74 MSeries B
Ripple Foods
Dec 2025Participated
$17 MOther Equity
Leal Therapeutics
Aug 2025Participated
$30 MSeries A
SetPoint Medical
Aug 2025Participated
$140 MSeries D
Savvy Wealth
Jul 2025Participated
$72 MSeries B
Actio Biosciences
Jun 2025Participated
$66 MSeries B
Zeitview
Mar 2025Participated
$60 MOther Equity
Leal Therapeutics
Oct 2024Participated
$45 MOther Equity
Circle Pharma
Sep 2026Participated
$93 MSeries E
Savvy Wealth
Sep 2026Participated
$100 MSeries C
Leal Therapeutics
Aug 2026Participated
$30 MSeries A
InduPro
Aug 2026Participated
$77 MSeries B
Nura Bio
Jun 2026Participated
$74 MSeries B
Ripple Foods
Dec 2025Participated
$17 MOther Equity
Leal Therapeutics
Aug 2025Participated
$30 MSeries A
SetPoint Medical
Aug 2025Participated
$140 MSeries D
Savvy Wealth
Jul 2025Participated
$72 MSeries B
Actio Biosciences
Jun 2025Participated
$66 MSeries B
Zeitview
Mar 2025Participated
$60 MOther Equity
Leal Therapeutics
Oct 2024Participated
$45 MOther Equity
54
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Euclidean Capital: 54 funding rounds are recorded in the selected participation categories.All available history.
Euclidean Capital: 54 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A111
Series B117
Series C+113
Other Equity19

Monthly Deal Activity

Euclidean Capital: 54 deals are recorded across 117 months.All available history.
Euclidean Capital: 54 deals are recorded across 117 months. All available history
MonthDeals
Feb '171
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '171
Oct '170
Nov '170
Dec '170
Jan '181
Feb '181
Mar '180
Apr '180
May '180
Jun '180
Jul '181
Aug '180
Sep '180
Oct '180
Nov '180
Dec '181
Jan '191
Feb '191
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '191
Nov '190
Dec '190
Jan '201
Feb '200
Mar '201
Apr '201
May '201
Jun '201
Jul '201
Aug '200
Sep '200
Oct '201
Nov '200
Dec '200
Jan '211
Feb '210
Mar '210
Apr '210
May '211
Jun '212
Jul '211
Aug '210
Sep '210
Oct '213
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '221
Jun '221
Jul '220
Aug '220
Sep '222
Oct '220
Nov '221
Dec '220
Jan '230
Feb '232
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '241
Feb '242
Mar '241
Apr '240
May '240
Jun '242
Jul '240
Aug '240
Sep '242
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '251
Jul '251
Aug '252
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '262
Sep '262
Oct '260

Sector Breakdown

Euclidean Capital: Health & Life Sciences is the largest displayed sector by deal count (35 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Euclidean Capital: Health & Life Sciences is the largest displayed sector by deal count (35 deals). All available history
SectorDeals
Health & Life Sciences35
AI & Machine Learning11
Space & Frontier Tech8
Enterprise Software7
Hardware & Robotics6
Fintech6
Networks, Cloud & Communication5
Clean Energy & Sustainability3
Real Estate & Construction3
Food & Agriculture2
Professional Services2
Government & Defense1
Cybersecurity & Privacy1
AR/VR1
Data, Analytics & IT1
Transportation & Logistics1
Marketing & Advertising1

Deal Size Distribution

Euclidean Capital: 54 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Euclidean Capital: 54 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M6
$25M-$50M11
$50M-$100M25
$100M-$250M11
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Euclidean Capital: United States has the largest recorded deal count among the displayed regions (53 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Euclidean Capital: United States has the largest recorded deal count among the displayed regions (53 deals). All available history
RegionDeals
United States53
Europe1
Euclidean Capital: 20 co-investors are shown, with The Column Group sharing 18 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Euclidean Capital: 20 co-investors are shown, with The Column Group sharing 18 recorded deals. All available history
Co-investorShared deals
The Column Group18
Alexandria Venture Investments9
Casdin Capital5
Deerfield Management5
Hearst Ventures5
OrbiMed5
Polaris Partners5
Team85
Eli Lilly and Company4
Illumina Ventures4
Lux Capital4
Nextech Invest4
Samsara BioCapital4
Two Sigma Ventures4
Union Square Ventures4
Canvas Prime3
Chugai Venture Fund3
Energy Transition Ventures3
Google Ventures3
Hartford HealthCare Endowment3

Investment Strategy

Euclidean Capital: Led accounts for 7% and participating for 93% of round participation.All available history.
Euclidean Capital: Led accounts for 7% and participating for 93% of round participation. All available history
CategoryDeals (count)Share (%)
Led47%
Participating5093%
Euclidean Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics.All available history.
Euclidean Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead375%
Co-led125%

Team

No team members found for this fund.